Variational AI

company

About

Generative AI for drug discovery

  • 1 - 10

Details

Last Funding Type
Pre-seed
Last Funding Money Raised
$210K
Industries
Artificial Intelligence,Biotechnology,Machine Learning
Founded date
Sep 1, 2019
Number Of Employee
1 - 10
Operating Status
Active

Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing its own internal pipeline.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$210K
Variational AI has raised a total of $210K in funding over 2 rounds. Their latest funding was raised on Jan 30, 2020 from a Pre-seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 30, 2020 Pre-seed $210K 1 UBC Seed Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Variational AI is funded by 1 investors. UBC Seed Fund are the most recent investors.
Investor Name Lead Investor Funding Round
UBC Seed Fund Yes Pre-seed